1,714
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

SATB1 mediated tumor colonization and β-catenin nuclear localization are associated with colorectal cancer progression

ORCID Icon, , , , & ORCID Icon
Article: 2320307 | Received 02 Dec 2023, Accepted 14 Feb 2024, Published online: 22 Feb 2024

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA-Cancer J Clin. 2020;70(1):7–11. doi:10.3322/caac.21590.
  • Siegel RL, Miller KD, Sauer AG, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2020. CA-Cancer J Clin. 2020;70(3):145–164. doi:10.3322/caac.21601.
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LAJemal A, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.
  • Naik R R, Galande S. SATB family chromatin organizers as master regulators of tumor progression. Oncogene. 2019;38(12):1989–2004. doi:10.1038/s41388-018-0541-4.
  • Pavan Kumar P, Purbey PK, Sinha CK, Notani D, Limaye A, Jayani RS, Galande S. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. Mol Cell. 2006;22(2):231–43. doi:10.1016/j.molcel.2006.03.010.
  • Mir R, Pradhan SJ, Patil P, Mulherkar R, Galande S. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression. Oncogene. 2016;35(13):1679–1691. doi:10.1038/onc.2015.232.
  • Lv JH, Wang F, Shen MH, Wang X, Zhou X-J. SATB1 expression is correlated with β-catenin associated epithelial–mesenchymal transition in colorectal cancer. Cancer Biol Ther. 2016;17(3):254–261. doi:10.1080/15384047.2016.1139239.
  • Zhang XL, Li CC, Wu Y, Cui P. The research progress of Wnt/β-catenin signaling pathway in colorectal cancer. Clin Res Hepatol Gastroenterol. 2023;47(3). doi:10.1016/j.clinre.2023.102086.
  • Disoma C, Zhou YZ, Li SN, Peng J, Xia Z. Wnt/β-catenin signaling in colorectal cancer: is therapeutic targeting even possible? Biochimie. 2022. 195:39–53. doi:10.1016/j.biochi.2022.01.009.
  • Liu JQ, Xiao Q, Xiao JN, Niu CX, Li YY, Zhang XJ, Zhou ZW, Shu G, Yin G. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7(1). doi:10.1038/s41392-021-00762-6.
  • Gong F, Sun L, Wang Z, Shi J, Li W, Wang S, Han X, Sun Y. The BCL2 gene is regulated by a special AT-rich sequence binding protein 1-mediated long range chromosomal interaction between the promoter and the distal element located within the 3′-UTR. Nucleic Acids Res. 2011;39(11):4640–4652. doi:10.1093/nar/gkr023.
  • Burute M, Gottimukkala K Galande K, Galande S. Chromatin organizer SATB1 is an important determinant of T-cell differentiation. Immunol Cell Biol. 2012;90(9):852–9. doi:10.1038/icb.2012.28.
  • Kitagawa Y, Ohkura N, Kidani Y, Vandenbon A, Hirota K, Kawakami R, Yasuda K, Motooka D, Nakamura S, Kondo M, et al. Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment. Nat Immunol. 2017;18(2):173–183. doi:10.1038/ni.3646.
  • Tu W, Luo M, Wang Z, Yan W, Xia Y, Deng H, He J, Han PTian P, Tian D. Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer. Liver Int. 2012;32(7):1064–78. doi:10.1111/j.1478-3231.2012.02815.x.
  • Yuan CL, Li L, Zhou X, Han L. Expression of SATB1 and HER2 in gastric cancer and its clinical significance. Eur Rev Med Pharmacol Sci. 2016;20(11):2256–64.
  • Xiang J, Zhou L, Li S, Xi X, Zhang J, Wang Y, Yang Y, Liu X, Wan X. AT-rich sequence binding protein 1: contribution to tumor progression and metastasis of human ovarian carcinoma. Oncol Lett. 2012;3(4):865–870. doi:10.3892/ol.2012.571.
  • Li YC, Bu LL, Mao L, Ma SR, Liu JF, Yu GT, Deng WW, WF Z, ZJ S. SATB1 promotes tumor metastasis and invasiveness in oral squamous cell carcinoma. Oral Dis. 2017;23(2):247–254. doi:10.1111/odi.12602.
  • Selinger CI, Cooper WA, Al-Sohaily S, Mladenova DN, Pangon L, Kennedy CW, McCaughan BC, Stirzaker C, MR K-C. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer. J Thorac Oncol. 2011;6(7):1179–1189. doi:10.1097/JTO.0b013e31821b4ce0.
  • Al-Sohaily S, Henderson C, Selinger C, Pangon L, Segelov E, MR K-C, Warusavitarne J. Loss of special AT-rich sequence-binding protein 1 (SATB1) predicts poor survival in patients with colorectal cancer. Histopathology. 2014;65(2):155–63. doi:10.1111/his.12295.
  • Nodin B, Johannesson H, Wangefjord S, O’Connor DP, Lindquist KE, Uhlen M, Jirstrom K Eberhard K. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer. Diagn Pathol. 2012;7(1):115. doi:10.1186/1746-1596-7-115.
  • Shapiro JR, WK Y, WR S. Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas. Cancer Res. 1981;41(6):2349–2359.
  • Lawson DA, Kessenbrock K, Davis RT, Pervolarakis N Werb N, Werb Z. Tumour heterogeneity and metastasis at single-cell resolution. Nat Cell Biol. 2018;20(12):1349–1360. doi:10.1038/s41556-018-0236-7.
  • Kormish JD, Sinner D, AM Z. Interactions between SOX factors and Wnt/beta-catenin signaling in development and disease. Dev Dynam. 2010;239(1):56–68. doi:10.1002/dvdy.22046.
  • Birchmeier W. The Wnt/beta-catenin signaling pathway in development and disease. Pathol Res Pract. 2007;203(5):341–341.
  • Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006;127(3):469–480. doi:10.1016/j.cell.2006.10.018.
  • Veeman MT, Axelrod JD, Moon RT. Axelrod JDMoon RT. A second canon: functions and mechanisms of beta-catenin-independent wnt signaling. Dev Cell. 2003;5(3):367–377. doi:10.1016/S1534-5807(03)00266-1.
  • Mir R, Pradhan SJ, Patil P, Mulherkar R, Galande S. Wnt/beta-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression. Oncogene. 2016;35(13):1679–1691. doi:10.1038/onc.2015.232.